Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer

Combating triple-negative breast cancer (TNBC) is still a problem, despite the development of numerous drug delivery approaches. Mucin1 (MUC1), a glycoprotein linked to chemo-resistance and progressive malignancy, is unregulated in TNBC. GO-201, a MUC1 peptide inhibitor that impairs MUC1 activity, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Behl, Akanksha, Solanki, Subhash, Paswan, Shravan K., Datta, Tirtha K., Saini, Adesh K., Saini, Reena V., Parmar, Virinder S., Thakur, Vijay Kumar, Malhotra, Shashwat, Chhillar, Anil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651876/
https://www.ncbi.nlm.nih.gov/pubmed/36405816
http://dx.doi.org/10.1007/s10924-022-02654-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651876/
https://www.ncbi.nlm.nih.gov/pubmed/36405816
http://dx.doi.org/10.1007/s10924-022-02654-4

Ejemplares similares